阿普达

#药闻简讯# $阿普达(ATR)$ 的 Bidose 鼻用系统输送 CARDAMYST™（etripamil），首个也是唯一一款 FDA 批准的自行给药鼻喷雾剂，用于治疗阵发性室上性心动过速（PSVT）

$阿普达(ATR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000896622-25-000033  Act: 34  Size: 12 MB 网页链接

$阿普达(ATR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-113973  Act: 33  Size: 905 KB 网页链接

$阿普达(ATR)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-25-113225  Act: 34  Size: 18 KB 网页链接

$阿普达(ATR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000896622-25-000035  Size: 6 KB 网页链接

$阿普达(ATR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-112983  Act: 33  Size: 749 KB 网页链接

$阿普达(ATR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000896622-25-000031  Act: 34  Size: 626 KB 网页链接

$阿普达(ATR)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-25-114637  Act: 34  Size: 628 KB 网页链接

$阿普达(ATR)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-010232  Act: 33  Size: 4 KB 网页链接

$阿普达(ATR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000896622-25-000039  Size: 8 KB 网页链接